Gastric non-hodgkin lymphoma

Summary

Gastric non-hodgkin lymphoma (MONDO:0042493) is a cancer. A subtype of gastric lymphoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gastric non-hodgkin lymphoma
Mondo ID	MONDO:0042493
NCIT	C27235
SNOMED CT	448709005
UMLS	C1333784
MedGen	232549
GARD	0000089
Anatomy (UBERON)	UBERON:0000945
Is cancer (heuristic)	yes

Also known as: gastric non-Hodgkin lymphoma · gastric non-Hodgkin’s lymphoma · lymphoma, gastric non Hodgkins type · non-Hodgkin lymphoma of stomach · non-Hodgkin’s lymphoma of stomach · non-Hodgkin’s lymphoma of the stomach · non-Hodgkins gastric lymphoma · primary gastric non-Hodgkin’s lymphoma · stomach lymphoma, non-Hodgkins type · stomach non-Hodgkin lymphoma

Disease family

This is a subtype of gastric lymphoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › gastric cancer › gastric lymphoma › gastric non-hodgkin lymphoma

Subtypes (2): gastric mantle cell lymphoma, gastric mucosa-associated lymphoid tissue lymphoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.